Huntsman Q3 2025 Earnings Report

Key highlights
  • Q3 2025 net loss was $25 million, with adjusted EBITDA at $94 million.
  • Free cash flow from continuing operations reached $157 million in Q3 2025.
  • Polyurethanes segment faced lower prices but higher volumes, impacting EBITDA.
  • Capital expenditures for 2025 are projected between $170 million to $180 million.

Financial Overview

In Q3 2025, Huntsman reported a net loss of $25 million, an improvement from the $33 million loss in the same period last year. Adjusted net loss was $5 million, down from a $17 million adjusted net income in Q3 2024. Adjusted EBITDA stood at $94 million, compared to $131 million in the previous year.

Cash Flow and Dividend

Net cash from operating activities was $200 million, with free cash flow from continuing operations at $157 million, up from $93 million in Q3 2024. The quarterly dividend was reset to $0.0875 per share, a 65% decrease, resulting in an annual payout of $0.35 per share.

Segment Performance

The Polyurethanes segment saw decreased revenues due to lower selling prices, despite higher sales volumes, particularly in the Americas and Asia. Performance Products experienced revenue declines from lower volumes and prices, impacted by the closure of the Moers facility and market conditions. Advanced Materials revenues increased due to favorable currency exchange rates, though EBITDA was slightly lower due to inventory reductions.

Capital Expenditures and Tax

Capital expenditures for Q3 2025 were $43 million, slightly up from $41 million in the same period last year. The company expects to spend $170 million to $180 million on capital expenditures in 2025. The effective tax rate for the quarter was -43%, with an adjusted rate of 40%.

Source: Huntsman

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

16 June 2026
Olin and Huntsman to merge as OlinHuntsman

All-stock merger creates an integrated North American chemicals platform with vertical chlorine/caustic integration, ~$12.5B pro forma revenue and $400M+ identified synergies.

30 July 2026
Huntsman Q2 2026 results and Olin merger update

Q2 net loss $6M, adjusted EBITDA $120M; free cash flow used $90M; signed all‑stock merger with Olin; stockholder vote Aug 25, 2026.

1 December 2025
Huntsman Revises Q4 2025 Outlook

An unplanned outage at the Rotterdam facility will likely reduce Q4 2025 adjusted EBITDA by $10 million, with production expected to resume mid-December.